SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis
SI-BONE Inc SIBN
$19.15
▲ +2.08%
(+$0.39)
⬆️ Above Yest. High
Open
$18.92
Prev Close
$18.76
Day Range
$18.61 – $19.60
52W Range
$11.48 – $21.89
Market Cap
$858.28M
Beta
0.67
EPS (TTM)
$-0.33
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2018-10-17 |
| Shares Out. | 44,350,000 |
| Website | si-bone.com/ ↗ |
| Phone | 14082070700 |
| Employees | 376 |
| Revenue | $56.0M |
| Gross Profit | $44.5M |
| Net Income | -$4.1M |
| Free Cash Flow | -$4.4M |
| Total Assets | $248.8M |
| Total Liabilities | $66.4M |
| Equity | $182.3M |
About SI-BONE Inc
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
SI-BONE Inc is a publicly traded company under the ticker symbol SIBN on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
16 analysts (2026-09-01)